Cargando…

Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

Lung adenocarcinoma (LUAD) is the most common histological lung cancer, and it is the leading cause of cancer-related deaths worldwide. LncRNA-AL139385.1 (ENSG00000275880) is a novel lncRNA that is abnormally expressed in various cancer types including LUAD. However, the underlying biological functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xi, Guo, Jishu, Zhou, Fan, Ren, Wenjun, Huang, Xiaobin, Pu, Jun, Niu, Xiaoqun, Jiang, Xiulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149219/
https://www.ncbi.nlm.nih.gov/pubmed/35651789
http://dx.doi.org/10.3389/fonc.2022.905871
_version_ 1784717160366473216
author Chen, Xi
Guo, Jishu
Zhou, Fan
Ren, Wenjun
Huang, Xiaobin
Pu, Jun
Niu, Xiaoqun
Jiang, Xiulin
author_facet Chen, Xi
Guo, Jishu
Zhou, Fan
Ren, Wenjun
Huang, Xiaobin
Pu, Jun
Niu, Xiaoqun
Jiang, Xiulin
author_sort Chen, Xi
collection PubMed
description Lung adenocarcinoma (LUAD) is the most common histological lung cancer, and it is the leading cause of cancer-related deaths worldwide. LncRNA-AL139385.1 (ENSG00000275880) is a novel lncRNA that is abnormally expressed in various cancer types including LUAD. However, the underlying biological function and potential mechanisms of AL139385.1 driving the progression of LUAD remain unclear. In this study, we investigated the role of AL139385.1 in LUAD and found that DNA hypomethylation was positively correlated with AL139385.1 expression in LUAD. Moreover, we uncover that the expression of AL139385.1 in LUAD tissues was significantly higher than that of AL139385.1 expression in adjacent normal tissues. Kaplan–Meier survival analysis showed that patients with higher AL139385.1 expression correlated with adverse overall survival and progression-free survival. Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) value of AL139385.1 was 0.808. Correlation analysis showed that AL139385.1 expression was associated with immune infiltration in LUAD. We also found that AL139385.1 was upregulated in LUAD cancer tissues and cell lines. Knockdown of AL139385.1 significantly inhibited cell proliferation and migration abilities of LUAD. Finally, we constructed a ceRNA network that includes hsa-miR-532-5p and four mRNAs (GALNT3, CYCS, EIF5A, and ITGB4) specific to AL139385.1 in LUAD. Subsequent Kaplan–Meier survival analysis suggested that polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3), cytochrome c, somatic (CYCS), eukaryotic translation initiation factor 5A (EIF5A), and integrin subunit beta 4 (ITGB4), were potential prognostic biomarkers for patients with LUAD. In conclusion, this finding provides possible mechanisms underlying the abnormal upregulation of AL139385.1 as well as a comprehensive view of the AL139385.1-mediated competing endogenous RNAs (ceRNA) network in LUAD, thereby highlighting its potential role in diagnosis and therapy.
format Online
Article
Text
id pubmed-9149219
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91492192022-05-31 Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma Chen, Xi Guo, Jishu Zhou, Fan Ren, Wenjun Huang, Xiaobin Pu, Jun Niu, Xiaoqun Jiang, Xiulin Front Oncol Oncology Lung adenocarcinoma (LUAD) is the most common histological lung cancer, and it is the leading cause of cancer-related deaths worldwide. LncRNA-AL139385.1 (ENSG00000275880) is a novel lncRNA that is abnormally expressed in various cancer types including LUAD. However, the underlying biological function and potential mechanisms of AL139385.1 driving the progression of LUAD remain unclear. In this study, we investigated the role of AL139385.1 in LUAD and found that DNA hypomethylation was positively correlated with AL139385.1 expression in LUAD. Moreover, we uncover that the expression of AL139385.1 in LUAD tissues was significantly higher than that of AL139385.1 expression in adjacent normal tissues. Kaplan–Meier survival analysis showed that patients with higher AL139385.1 expression correlated with adverse overall survival and progression-free survival. Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) value of AL139385.1 was 0.808. Correlation analysis showed that AL139385.1 expression was associated with immune infiltration in LUAD. We also found that AL139385.1 was upregulated in LUAD cancer tissues and cell lines. Knockdown of AL139385.1 significantly inhibited cell proliferation and migration abilities of LUAD. Finally, we constructed a ceRNA network that includes hsa-miR-532-5p and four mRNAs (GALNT3, CYCS, EIF5A, and ITGB4) specific to AL139385.1 in LUAD. Subsequent Kaplan–Meier survival analysis suggested that polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3), cytochrome c, somatic (CYCS), eukaryotic translation initiation factor 5A (EIF5A), and integrin subunit beta 4 (ITGB4), were potential prognostic biomarkers for patients with LUAD. In conclusion, this finding provides possible mechanisms underlying the abnormal upregulation of AL139385.1 as well as a comprehensive view of the AL139385.1-mediated competing endogenous RNAs (ceRNA) network in LUAD, thereby highlighting its potential role in diagnosis and therapy. Frontiers Media S.A. 2022-05-16 /pmc/articles/PMC9149219/ /pubmed/35651789 http://dx.doi.org/10.3389/fonc.2022.905871 Text en Copyright © 2022 Chen, Guo, Zhou, Ren, Huang, Pu, Niu and Jiang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Chen, Xi
Guo, Jishu
Zhou, Fan
Ren, Wenjun
Huang, Xiaobin
Pu, Jun
Niu, Xiaoqun
Jiang, Xiulin
Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
title Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
title_full Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
title_fullStr Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
title_full_unstemmed Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
title_short Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
title_sort long non-coding rna al139385.1 as a novel prognostic biomarker in lung adenocarcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149219/
https://www.ncbi.nlm.nih.gov/pubmed/35651789
http://dx.doi.org/10.3389/fonc.2022.905871
work_keys_str_mv AT chenxi longnoncodingrnaal1393851asanovelprognosticbiomarkerinlungadenocarcinoma
AT guojishu longnoncodingrnaal1393851asanovelprognosticbiomarkerinlungadenocarcinoma
AT zhoufan longnoncodingrnaal1393851asanovelprognosticbiomarkerinlungadenocarcinoma
AT renwenjun longnoncodingrnaal1393851asanovelprognosticbiomarkerinlungadenocarcinoma
AT huangxiaobin longnoncodingrnaal1393851asanovelprognosticbiomarkerinlungadenocarcinoma
AT pujun longnoncodingrnaal1393851asanovelprognosticbiomarkerinlungadenocarcinoma
AT niuxiaoqun longnoncodingrnaal1393851asanovelprognosticbiomarkerinlungadenocarcinoma
AT jiangxiulin longnoncodingrnaal1393851asanovelprognosticbiomarkerinlungadenocarcinoma